s-nitroso-n-acetylpenicillamine has been researched along with Heart Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boysen, PG; Ji, X; Xu, Z | 1 |
| Horton, JW; Maass, D; Sanders, B; White, J | 1 |
2 other study(ies) available for s-nitroso-n-acetylpenicillamine and Heart Diseases
| Article | Year |
|---|---|
Exogenous nitric oxide generates ROS and induces cardioprotection: involvement of PKG, mitochondrial KATP channels, and ERK.
Topics: Animals; Blotting, Western; Cyclic AMP-Dependent Protein Kinases; Enzyme Activators; Enzyme Inhibitors; Heart Diseases; Hemodynamics; In Vitro Techniques; Male; Membrane Proteins; Mitochondria; Mitogen-Activated Protein Kinases; Myocardial Infarction; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Donors; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Potassium Channels; Rats; Rats, Wistar; Reactive Oxygen Species; S-Nitroso-N-Acetylpenicillamine; Signal Transduction | 2004 |
Nitric oxide modulation of TNF-alpha-induced cardiac contractile dysfunction is concentration dependent.
Topics: Animals; Azetidines; Dose-Response Relationship, Drug; Heart Diseases; Hydrazines; In Vitro Techniques; Myocardial Contraction; Myocardium; Nitric Oxide; Nitric Oxide Donors; Osmolar Concentration; Penicillamine; Rats; Rats, Sprague-Dawley; S-Nitroso-N-Acetylpenicillamine; Tumor Necrosis Factor-alpha | 2000 |